Transcriptional regulatory networks underlying gene expression changes in Huntington's disease
JournalMolecular Systems Biology
MetadataShow full item record
AbstractTranscriptional changes occur presymptomatically and throughout Huntington's disease (HD), motivating the study of transcriptional regulatory networks (TRNs) in HD. We reconstructed a genome-scale model for the target genes of 718 transcription factors (TFs) in the mouse striatum by integrating a model of genomic binding sites with transcriptome profiling of striatal tissue from HD mouse models. We identified 48 differentially expressed TF-target gene modules associated with age- and CAG repeat length-dependent gene expression changes in Htt CAG knock-in mouse striatum and replicated many of these associations in independent transcriptomic and proteomic datasets. Thirteen of 48 of these predicted TF-target gene modules were also differentially expressed in striatal tissue from human disease. We experimentally validated a specific model prediction that SMAD3 regulates HD-related gene expression changes using chromatin immunoprecipitation and deep sequencing (ChIP-seq) of mouse striatum. We found CAG repeat length-dependent changes in the genomic occupancy of SMAD3 and confirmed our model's prediction that many SMAD3 target genes are downregulated early in HD. Copyright 2018 The Authors. Published under the terms of the CC BY 4.0 license
SponsorsThis work was supported in part by a contract from the CHDI Foundation (N.D.P., Principal Investigator, and J.B.C, Principal Investigator) and with internal funds from the Institute for Systems Biology. J.R.P. was supported by a National Science Foundation Graduate Research Fellowship. D.E.B. was supported by a Donald A. King summer fellowship from the Huntington's Disease Society of America, and J.B.C. was supported by Huntington Society of Canada New Pathways Program.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85044716041&doi=10.15252%2fmsb.20167435&partnerID=40&md5=15138b257aa207fa6e5d529684bf18a8; http://hdl.handle.net/10713/9656
- Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.
- Authors: Choudhury KR, Das S, Bhattacharyya NP
- Issue date: 2016 Jan 30
- Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice.
- Authors: Achour M, Le Gras S, Keime C, Parmentier F, Lejeune FX, Boutillier AL, Néri C, Davidson I, Merienne K
- Issue date: 2015 Jun 15
- Altered enhancer transcription underlies Huntington's disease striatal transcriptional signature.
- Authors: Le Gras S, Keime C, Anthony A, Lotz C, De Longprez L, Brouillet E, Cassel JC, Boutillier AL, Merienne K
- Issue date: 2017 Feb 22
- Systems Genetic Analyses Highlight a TGFβ-FOXO3 Dependent Striatal Astrocyte Network Conserved across Species and Associated with Stress, Sleep, and Huntington's Disease.
- Authors: Scarpa JR, Jiang P, Losic B, Readhead B, Gao VD, Dudley JT, Vitaterna MH, Turek FW, Kasarskis A
- Issue date: 2016 Jul
- High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington's disease CAG knock-in mice across multiple genetic backgrounds.
- Authors: Ament SA, Pearl JR, Grindeland A, St Claire J, Earls JC, Kovalenko M, Gillis T, Mysore J, Gusella JF, Lee JM, Kwak S, Howland D, Lee MY, Baxter D, Scherler K, Wang K, Geman D, Carroll JB, MacDonald ME, Carlson G, Wheeler VC, Price ND, Hood LE
- Issue date: 2017 Mar 1